Patent · US Active

Protein Arginine Deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer

US8921595B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

UNIVERSITY OF SOUTH CAROLINA · US

Inventors

Paul R. Thompson · Columbia, US
Corey P. Causey · Jacksonville, US

Key dates

Filing date	Oct 25, 2010
Grant date	Dec 30, 2014
Priority date	—
Expiry date	Aug 16, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

In accordance with certain embodiments of the present disclosure, a self-assembling biodegradable nanoparticle is provided. The nanoparticle includes Cys-Val-Val-Val-Val-Val-Val-Lys-Lys conjugated with a synthetic polymer and has a diameter of from about 50 nm to about 150 nm.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.